IRIS
ARNALDI, Giorgio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.181
EU - Europa 2.305
AS - Asia 361
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 4
AF - Africa 1
Totale 7.858
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.177
UA - Ucraina 511
IE - Irlanda 420
IT - Italia 381
SE - Svezia 324
DE - Germania 244
DK - Danimarca 143
GB - Regno Unito 137
SG - Singapore 137
TR - Turchia 104
FI - Finlandia 91
KR - Corea 67
BE - Belgio 31
IN - India 21
CN - Cina 17
IR - Iran 9
RU - Federazione Russa 7
AT - Austria 4
AU - Australia 4
CA - Canada 4
EU - Europa 4
FR - Francia 4
NL - Olanda 4
VN - Vietnam 3
JO - Giordania 2
NZ - Nuova Zelanda 2
BG - Bulgaria 1
CI - Costa d'Avorio 1
ES - Italia 1
JP - Giappone 1
NO - Norvegia 1
RO - Romania 1
Totale 7.858
Salva come PNG Salva come JPEG
Città #
Chandler 687
Jacksonville 672
Des Moines 455
Fairfield 426
Dublin 420
Ashburn 320
Wilmington 219
Woodbridge 191
New York 184
Boardman 176
Seattle 173
Ann Arbor 162
Lawrence 162
Princeton 162
San Mateo 151
Houston 136
Cambridge 128
Centro 93
San Diego 55
Turin 39
Brussels 29
Los Angeles 27
Helsinki 25
London 24
Washington 24
Norwalk 21
Pune 19
Civitanova Marche 16
Rome 14
New Bedfont 13
Beijing 12
Falls Church 10
Kilburn 10
Ascoli Piceno 9
Pescara 9
Redmond 9
Ancona 7
Chiswick 7
Karaj 7
Camerino 5
Marche 5
Senigallia 5
Vallefoglia 5
Altenmarkt im Pongau 4
Auburn Hills 4
Istia D'ombrone 4
Ivrea 4
Macerata 4
Naples 4
Ravenna 4
Avellino 3
Como 3
Filottrano 3
Grumo Nevano 3
Hanover 3
Hounslow 3
Islington 3
Massarosa 3
Milan 3
Modugno 3
Monsampolo del Tronto 3
Padova 3
Porto San Giorgio 3
Prescot 3
Amman 2
Bologna 2
Boydton 2
Castelfidardo 2
Dong Ket 2
Marano di Napoli 2
Montréal 2
New Delhi 2
Nowshahr 2
Parma 2
Perugia 2
Pesaro 2
Redwood City 2
San Jose 2
Solna 2
Sydney 2
Tianjin 2
Venice 2
Waanrode 2
Abidjan 1
Acton 1
Amsterdam 1
Aradeo 1
Auckland 1
Barcelona 1
Cantu 1
Chicago 1
Fano 1
Foresto 1
Frankfurt am Main 1
Hangzhou 1
Harrisburg 1
Ho Chi Minh City 1
Iesi 1
Irvine 1
Isorella 1
Totale 5.448
Salva come PNG Salva come JPEG
Nome #
Isolation and characterization of progenitor mesenchymal cells in human pituitary tumors. 118
ISOLATION AND CHARACTERIZATION OF MESENCHYMAL CELLS FROM PITUITARY TUMOURS 113
Age-related modifications of the human growth hormone circadian secretory pattern studied with a new statistical method in healthy adults 98
Impact of COVID-19 pandemic on psychophysical stress in patients with adrenal insufficiency: the CORTI-COVID study 98
Pituitary adenomas, stem cells, and cancer stem cells: what's new? 97
Desmopressin test in the differential diagnosis of Pseudo-Cushing state from Cushing’s disease. 89
Effects of long-term treatment with human pure FSH on seminal parameters and sperm cells ultrastructure in idiopathic oligo-asthenozoospermia. 88
Adrenal incidentaloma: surgical update. 88
Importance of sleep and melatonin for the human prolactin circadian secretory pattern in normal and pathological conditions 84
Cushing Syndrome: The Role of MSCs in Wound Healing, Immunosuppression, Comorbidities, and Antioxidant Imbalance 84
Diagnosis and complications of Cushing's syndrome: a consensus statement 83
RNA sequencing and somatic mutation status of adrenocortical tumors: novel pathogenetic insights 83
Human corticotropin releasing hormone test performance in the differential diagnosis between Cushing's disease and pseudo-Cushing state is enhanced by combined ACTH and cortisol analysis. 82
COVID-19 infection and glucocorticoids: update from the Italian Society of Endocrinology Expert Opinion on steroid replacement in adrenal insufficiency 82
ACROSCORE: a new and simple tool for the diagnosis of acromegaly, a rare and underdiagnosed disease. 80
Unusual clinical manifestation of pheochromocytoma in a MEN2A patient 77
Qualità della vita nei pazienti con sindrome adrenogenitale ed impatto della terapia sostitutiva. 77
The medical treatment with pasireotide in Cushing’s disease: an Italian multicentre experience based on “real-world evidence” 75
Ruolo dell’osmolarità seminale nella regolazione della motilità degli spermatozoi nell’uomo 74
Body composition and metabolic features in women with adrenal incidentaloma or Cushing's syndrome. 74
Effects of somatostatin and its analogues on progenitor mesenchymal cells isolated from human pituitary adenomas 73
Bone complications in patients with Cushing's syndrome: looking for clinical, biochemical, and genetic determinants. 73
High-dose and high-frequency lanreotide autogel in acromegaly: A randomized, multicenter study 72
The diagnostic accuracy of increased late night salivary cortisol for Cushing's syndrome: a real-life prospective study 72
Decreased expression of insulin-sensitive glucose transporter mRNA (GLUT-4) in adipose tissue of non-insulin-dependent diabetic and obese patients: evaluation by a simplified quantitative PCR assay. 72
Self image and quality of life in acromegaly 71
Changes in adenosine 5'-monophosphate-activated protein kinase as a mechanism of visceral obesity in Cushing's syndrome. 71
Echo Doppler in the characterization of thyroid nodular disease 69
Safety and effectiveness of Omnitrope® in patients with growth hormone deficiency: snapshot analysis of PATRO Adults study in the Italian population 69
How to improve effectiveness of pegvisomant treatment in acromegalic patients 68
Advances in the epidemiology, pathogenesis, and management of Cushing's syndrome complications. 66
Mitotane Concentrations Influence the Risk of Recurrence in Adrenocortical Carcinoma Patients on Adjuvant Treatment 66
ENSAT registry-based randomized clinical trials for adrenocortical carcinoma 66
Towards the tailoring of glucocorticoid replacement in adrenal insufficiency: the Italian Society of Endocrinology Expert Opinion 66
Use of the desmopressin test in the differential diagnosis of pseudo-Cushing state from Cushing's disease 62
Determinazione comparativa dei livelli del coenzima Q10 nelle oligozoospermie idiopatiche e nel varicocele 62
Analisys of Y-linked microdeletions in idiopathic oligo- and azoospermic patients 62
New treatment guidelines on Cushing's disease. 61
ADRENAL MORPHO-FUNCTIONAL ALTERATIONS IN PATIENTS WITH ACROMEGALY. 61
Glucocorticoid excess and COVID-19 disease 61
Pituitary adenoma apoplexy: Review of personal series. 60
High cardiovascular risk in patients with Cushing's syndrome accorìging to 1999 WHO/ISH guidelines 60
Corticotropin-releasing hormone and desmopressin tests in the differential diagnosis between Cushing's disease and Pseudo-Cushing state: a comparative study. 59
Diagnostic accuracy of increased urinary cortisol/cortisone ratio to differentiate ACTH-dependent Cushing's syndrome 59
Somatic PRKACA Mutations: Association With Transition From Pituitary-Dependent to Adrenal-Dependent Cushing Syndrome 59
Primary adrenal hypercortisolism: minimally invasive surgical treatment or medical therapy? A retrospective study with long-term follow-up evaluation. 59
Cyclical Cushing's syndrome in a patient with a bronchial neuroendocrine tumor (typical carcinoid) expressing ghrelin and growth hormone secretagogue receptors. 59
Androgens in Cushing's Syndrome 59
Long-term treatment of Cushing’s disease with pasireotide: 5-year results from an open-label extension study of a Phase III trial 59
Expression of growth hormone-releasing hormone receptor splicing variants in human primary adrenocortical tumours 58
Sexual Dysfunctions in Men Affected by Autoimmune Addison's Disease Before and After Short-Term Gluco- and Mineralocorticoid Replacement Therapy 58
AMP-activated protein kinase mediates glucocorticoid-induced metabolic changes: a novel mechanism in Cushing's syndrome 57
Semen osmolarity and sperm motility 57
Mitotane concentrations influence outcome in patients with advanced adrenocortical carcinoma 57
Coenzyme Q10 levels in idiopathic and varicocele-associated asthenozoospermia 56
Acromegaly Is More Severe in Patients With AHR or AIP Gene Variants Living in Highly Polluted Areas 55
Prognostic factors in ectopic Cushing's syndrome due to neuroendocrine tumors: A multicenter study 55
Efficacy and safety of once-monthly pasireotide in Cushing's disease: a 12 month clinical trial 55
Association of glucocorticoid receptor polymorphism A3669G with decreased risk of developing diabetes in patients with Cushing's syndrome 55
Harmful effects of functional hypercortisolism: a working hypothesis. 55
Approach to hyponatremia according to the clinical setting: Consensus statement from the Italian Society of Endocrinology (SIE), Italian Society of Nephrology (SIN), and Italian Association of Medical Oncology (AIOM) 55
A novel endothelial tyrosine kinase cDNA homologous to platelet-derived growth factor receptor cDNA. 54
Analysis of GRP101 and AIP genes mutations in acromegaly: a multicentre study 54
A Single-Center 10-Year Experience with Pasireotide in Cushing's Disease: Patients' Characteristics and Outcome. 54
The role of an acute pasireotide suppression test in predicting response to treatment in patients with Cushing’s disease: findings from a pilot study 54
Enhanced expression of transforming growth factor beta 1 in rat thyroid hyperplasia is thyrotropin induced and time dependent 53
An evaluation of the ultrastructural features improvement in idiopathic oligo-astenospermia after FSH treatment 53
Isolation and characterization of Mesenchymal Stem Cells from pituitary tumours 52
Fine-needle aspiration cytology of adrenal masses: a re-assessment with histological confirmation. 51
A multicenter experience on the prevalence of ARMC5 mutations in patients with primary bilateral macronodular adrenal hyperplasia: from genetic characterization to clinical phenotype 51
Cardiovascular risk in Cushing's syndrome. 50
Is pasireotide-induced diabetes mellitus predictable? A pilot study on the effect of a single dose of pasireotide on glucose homeostasis 50
Reduced expression of the growth hormone and type 1 insulin-like growth factor receptors in human somatotroph tumours and an analysis of possible mutations of the growth hormone receptor. 49
null 49
Telomerase activity is significantly enhanced in malignant adrenocortical tumors in comparison to benign adrenocortical adenomas. 48
Adrenal incidentaloma. 47
Protective role of ubiquinol-10 against peroxidation in human seminal fluid plasma 47
Coagulopathy in Cushing's syndrome. 46
Advances in medical treatment of Cushing’s disease 46
Acromegaly and male sexual health 45
Salivary cortisol is a useful tool to assess the early response to pasireotide in patients with Cushing's disease. 45
Mesenchymal Stem Cells Exposed to Persistently High Glucocorticoid Levels Develop Insulin-Resistance and Altered Lipolysis: A Promising In Vitro Model to Study Cushing’s Syndrome 45
Hypertension-induced changes of platelet-derived growth factor receptor expression in rat aorta and heart. 44
First-line therapy of acromegaly: A statement of the A.L.I.C.E. (Acromegaly primary medical treatment Learning and Improvement with Continuous Medical Education) Study Group 44
Adrenal incidentaloma: an overview of hormonal data from the National Italian Study Group. 44
Conventional and nuclear medicine imaging in Ectopic Cushing's syndrome: A systematic review 44
Decreased resistance to toxicity of reactive oxygen species in seminal plasma of asthenospermic individuals 44
Pituitary-directed medical treatment of Cushing’s disease. 43
Histological contamination in clinical research: from ultrastrcture to stem cel biology. 43
ACTH receptor mRNA in human adrenocortical tumors: overexpression in aldosteronomas. 42
Effects of exogenous CoQ10 administration in patients with idiopathic asthenozoospermia 42
Treatment-related fatigue with sorafenib, sunitinib and pazopanib in patients with advanced solid tumors: an up-to-date review and meta-analysis of clinical trials 41
Potential indications for somatostatin analogs in Cushing's syndrome. 40
Approach to the patient with possible Cushing's syndrome 40
Up-to 5-year efficacy of pasireotide in a patient with Cushing's disease and pre-existing diabetes: literature review and clinical practice considerations 40
High cardiovascular risk in patients with Cushing's syndrome according to 1999 WHO/ISH guidelines. 40
The degree of urinary hypercortisolism is not correlated with the severity of Cushing's syndrome. 40
Sodium alterations impair the prognosis of hospitalized patients with COVID-19 pneumonia 40
Increased frequency of the rs2066853 variant of aryl hydrocarbon receptor gene in patients with acromegaly. 39
AME position statement on adrenal incidentaloma. 39
Totale 6.085
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.891
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.891
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201925 0 0 0 0 0 0 0 0 0 0 16 9
2019/2020655 2 2 78 5 92 7 91 7 96 4 85 186
2020/20211.942 86 200 249 30 208 93 227 183 218 148 200 100
2021/20221.141 60 225 29 68 7 77 41 90 80 101 104 259
2022/20232.335 211 235 166 178 109 613 6 105 530 11 123 48
2023/20241.197 237 45 122 179 215 277 38 32 7 42 3 0
Totale 8.075